CoChat

Human Type 3 3α-Hydroxysteroid Dehydrogenase (Aldo-Keto Reductase 1C2) and Androgen Metabolism in Prostate Cells

Rižner, Tea Lanišnik, Lin, Hsueh K., Peehl, Donna M., Steckelbroeck, Stephan, Bauman, David R., Penning, Trevor M. · 2003 · Endocrinology

The DOI matches its Crossref record; 31 of the 33 references it cites were found in a registry or an index.

Abstract

Human aldo-keto reductases (AKRs) of the AKR1C subfamily function in vitro as 3-keto-, 17-keto-, and 20-ketosteroid reductases or as 3α-, 17β-, and 20α-hydroxysteroid oxidases. These AKRs can convert potent sex hormones (androgens, estrogens, and progestins) into their cognate inactive metabolites or vice versa. By controlling local ligand concentration AKRs may regulate steroid hormone action at the prereceptor level. AKR1C2 is expressed in prostate, and in vitro it will catalyze the nicotinamide adenine dinucleotide (NAD+)-dependent oxidation of 3α-androstanediol (3α-diol) to 5α-dihydrotestosterone (5α-DHT). This reaction is potently inhibited by reduced NAD phosphate (NADPH), indicating that the NAD+: NADPH ratio in cells will determine whether AKR1C2 makes 5α-DHT. In transient COS-1-AKR1C2 and in stable PC-3-AKR1C2 transfectants, 5α-DHT was reduced by AKR1C2. However, the transfected AKR1C2 oxidase activity was insufficient to surmount the endogenous 17β-hydroxysteroid dehydrogenase (17β-HSD) activity, which eliminated 3α-diol as androsterone. PC-3 cells expressed retinol dehydrogenase/3α-HSD and 11-cis-retinol dehydrogenase, but these endogenous enzymes did not oxidize 3α-diol to 5α-DHT. In stable LNCaP-AKR1C2 transfectants, AKR1C2 did not alter androgen metabolism due to a high rate of glucuronidation. In primary cultures of epithelial cells, high levels of AKR1C2 transcripts were detected in prostate cancer, but not in cells from normal prostate. Thus, in prostate cells AKR1C2 acts as a 3-ketosteroid reductase to eliminate 5α-DHT and prevents activation of the androgen receptor. AKR1C2 does not act as an oxidase due to either potent product inhibition by NADPH or because it cannot surmount the oxidative 17β-HSD present. Neither AKR1C2, retinol dehydrogenase/3α-HSD nor 11-cis-retinol dehydrogenase is a source of 5α-DHT in PC-3 cells.

Overview

Integrity signals

Registry

Crossref · 10.1210/en.2002-0032

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Research works printed but not linked: 3

  1. Griffiths, 1999, Aspects of the cell biology of prostate cancer, 51
  2. Barbier, 2000, Cellular localization of uridine diphosphoglucronsyltransferase 2B enzymes in the human prostate by in situ hybridization and immunohistichemistry., J Clin Endocrinol Metab, 85, 4819
  3. Peehl, 1992, Culture of human prostate epithelial cells, 159

Cited by

See all 136

Metadata

Authors
Rižner, T. L., Lin, H. K., Peehl, D. M., Steckelbroeck, S., Bauman, D. R., & Penning, T. M.
Affiliations
  • Department of Pharmacology, University of Pennsylvania School of Medicine (T.L.R., T.M.P., S.S., D.M.B.), Philadelphia, Pennsylvania 19104-6084
  • University of Oklahoma Health Sciences Center (US)
  • University of Pennsylvania (US)
  • Stanford Medicine (US)
Corresponding author
Penning, Trevor M.
Venue
Endocrinology
Published
2003-07-01
Volume
144
Issue
7
Pages
2922-2932
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2125072209
Cited by
132
References
33
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 7 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 7 · 2018: 3 · 2017: 5 · 2016: 10 · 2014: 10 · 2013: 10 · 2012: 3
FWCI
4.02
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Cancer Institute (CA 97044)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK54925, DK-47015, R01DK054925, R01DK047015)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
Keywords
3α-hydroxysteroid dehydrogenase, AKR1C2, aldo-keto reductase, androgen metabolism, dihydrotestosterone, 3α-androstanediol, 17β-hydroxysteroid dehydrogenase, androgen receptor activation, prostate cancer, PC-3 cells, LNCaP cells, glucuronidation
MeSH terms
Adenocarcinoma, Animals, Bone Neoplasms, Epithelial Cells, Humans, Hydroxysteroid Dehydrogenases, Isoenzymes, Male, Prostate, Prostatic Neoplasms, Dihydrotestosterone, Testosterone, Tumor Cells, Cultured, 17-Hydroxysteroid Dehydrogenases, Androstane-3,17-diol, Gene Expression Regulation, Enzymologic, COS Cells, 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific), In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.